A novel antagonist to the inhibitors of apoptosis (IAPs) potentiates cell death in EGFR-overexpressing non-small-cell lung cancer cells

SH Lee(Samsung Medical Center), S. J. Jang(Ulsan College)

Cell Death and Disease

October 16, 2014

10.1038/cddis.2014.447

Cited by 20

Related Papers

Tick surveillance of dogs in the Republic of Korea

|Systematic and Applied Acarology|2011|20

927TiP SKYSCRAPER-09: A phase II, randomised, double-blinded study of atezolizumab (Atezo) + tiragolumab (Tira) and atezo + placebo as first-line (1L) therapy for recurrent/metastatic (R/M) PD-L1+ squamous cell carcinoma of the head and neck (SCCHN)

|Annals of Oncology|2021|4